Accessibility Menu
Strata Critical Medical logo

Strata Critical Medical(NASDAQ) SRTA

Market Cap$504.26MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)-42%
5 Year-26%
1 Year+37%
1 Month+11%
$5.70
-3.39%
-0.20Today
Strata Critical Medical last closing stock price
MetricPriceDate
Last closeUSD 5.702026-08-18
Strata Critical Medical stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-5.47%USD 6.032026-08-11
1 month+10.68%USD 5.152026-07-17
3 month+2.89%USD 5.542026-05-20
Year to date+18.5%USD 4.812025-12-31
1 year+36.69%USD 4.172025-08-18
3 year+67.65%USD 3.402023-08-18
5 year-26.26%USD 7.732021-08-19
Since inception-41.54%USD 9.752019-11-05

Strata Critical Medical Financials at a Glance

Market Cap

$504.26MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$255.98M

Net Income (TTM)

$40.22M

EPS (TTM)

-$0.19

P/E Ratio

-29.52

Dividend

$0.00

Beta (Volatility)

1.59 (High)

Price

$5.70

Volume

180

Open

$5.80

Previous Close

$5.70

Daily Range

$5.68 - $5.90

52-Week Range

$3.85 - $6.50

Estimated Earnings Date

Nov 9, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Strata Critical Medical

Strata Critical Medical, Inc. helps hospitals move human organs quickly. It uses planes and cars to save lives across the United States. The company also sends expert staff to help with heart surgeries.

Helping Organs Reach Patients

  • Air Logistics: Arranges private plane transport for organs, surgical teams, and medical equipment.
  • Ground Logistics: Manages ambulance and vehicle transport for organs and staff to hospitals.
  • Organ Recovery: Conducts surgical procedures to remove donor organs for transplant patients.
  • Cardiac Care: Supplies expert staff and machines to keep blood flowing during heart surgeries.
  • Organ Placement: Assists transplant centers in evaluating donor organs for specific patients.

A Rapidly Growing Network

  • Sold the passenger transportation business to Joby Aviation in Aug. 2025.
  • Acquired Keystone in Sept. 2025 to add surgical recovery and organ preservation services.
  • Purchased Ohio Valley Perfusion Associates in April 2026 to expand heart surgery support.
  • Bought Louisville Perfusion Services in June 2026 to grow its Kentucky presence.
  • Acquired HLT-NRP in June 2026 to add more transplant surgeons to its network.

Why Strata Is Different

Strata uses an asset-light model that relies on third-party planes to keep costs flexible. Its proprietary technology tracks medical teams and organ shipments to ensure fast delivery. These digital tools help hospitals evaluate donor organs more efficiently.

The Latest Financial Figures

  • Revenue was $139.9 million in the six-month period ended June 30, 2026, up 72.6% year over year.
  • Adjusted EBITDA was $14.3 million in the six-month period ended June 30, 2026, up 396.1% year over year.
  • Net loss was $8.4 million in the six-month period ended June 30, 2026, compared to a $7.2 million loss in 2025.
  • Total liquidity was $22.8 million as of June 30, 2026, including cash and short-term investments.

A New Healthcare Focus

Strata has successfully shifted from a general aviation company to a specialized medical services provider. Its recent acquisitions and the sale of its passenger business show a clear focus on the transplant and cardiac care markets.

AI Generated • Aug 5, 2026

Industry

Healthcare Providers and Services

Employees

601

CEO

William A. Heyburn; Melissa M. Tomkiel

Headquarters

New York, NY 10001, US

SRTA Financials

Key Financial Metrics (TTM)

Gross Margin

20.56%

Operating Margin

-7.97%

Net Income Margin

15.71%

Return on Equity

14.27%

Return on Capital

-7.92%

Return on Assets

12.09%

Earnings Yield

-3.39%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$504.26MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

88.47M

Volume

180

Avg. Volume

1.16M

Financials (TTM)

Gross Profit

$52.62M

Operating Income

-$20.41M

EBITDA

-$9.36M

Operating Cash Flow

-$30.90M

Capital Expenditure

-$12.80M

Free Cash Flow

-$43.70M

Cash & ST Invst.

$22.75M

Total Debt

$4.26M

Strata Critical Medical Performance Analysis

Strata Critical Medical annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 146,120,000189.2%
20232023-12-31USD 225,180,00054.1%
20242024-12-31USD 146,817,000-34.8%
20252025-12-31USD 197,141,00034.3%
Strata Critical Medical sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-30.4%
Q42025-12-3135.5%
Q12026-03-310.9%
Q22026-06-307.6%
Strata Critical Medical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.38-59.0%
20232023-12-31USD -0.7699.3%
20242024-12-31USD -0.35-53.8%
20252025-12-31USD -0.19-45.9%
Strata Critical Medical sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-301621.7%
Q42025-12-31-115.7%
Q12026-03-31125.2%
Q22026-06-30-533.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$72.51M

+2.4%

Gross Profit

$15.22M

-14.2%

Gross Margin

20.98%

N/A

Market Cap

$504.26MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.54M

N/A

Employees

327

N/A

Net Income

-$10.52M

-181.0%

EBITDA

-$2.00M

-2.8%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$22.75M

-79.9%

Total Debt

$4.26M

-51.9%

Accounts Receivable

$43.41M

+54.1%

Inventory

$164.00K

N/A

Long Term Debt

$3.20M

-39.8%

Short Term Debt

$1.05M

-70.1%

Return on Assets

12.09%

N/A

Return on Invested Capital

-7.11%

N/A

Free Cash Flow

$3.50M

+160.4%

Operating Cash Flow

$5.69M

+285.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ULHUniversal Logistics Holdings, Inc.
$19.28-1.38%
EBFEnnis, Inc.
$22.53+0.94%
ZIPZipRecruiter, Inc.
$4.97+2.26%
ORNOrion Group Holdings, Inc.
$9.55-2.65%

Trending Stocks

Symbol / CompanyPricePrice Chg
KORUDirexion Shares ETF Trust - Direxion Daily Msci South Korea Bull 3x Shares
$17.84-0.24%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$44.19+0.15%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$129.10-0.15%
NOKNokia
$10.39-0.04%

Questions About SRTA

What is the current price of Strata Critical Medical?

Strata Critical Medical is trading at $5.70 per share.

What is the 52-week range for Strata Critical Medical?

Over the past 52 weeks, Strata Critical Medical has traded between $3.85 and $6.50.

How much debt does Strata Critical Medical have?

As of the most recent reporting period, Strata Critical Medical reported total debt of $4.26M.

How much cash does Strata Critical Medical have on hand?

Strata Critical Medical reported $16.58M in cash and cash equivalents in its most recent financial results.

What is Strata Critical Medical’s dividend yield?

Strata Critical Medical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.